Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.04 | 1.72 |
NAV | ₹17.74 | ₹187.03 |
Fund Started | 28 Jul 2022 | 15 Feb 2007 |
Fund Size | ₹1957.21 Cr | ₹9319.87 Cr |
Exit Load | Exit load of 1%, if redeemed within 1 year. | Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 1.38% | 12.39% |
3 Year | 20.93% | 27.36% |
5 Year | - | 25.90% |
1 Year
3 Year
5 Year
Equity | 98.20% | 99.43% |
Cash | 1.79% | 0.57% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Prestige Estates Projects Ltd. | 3.09% |
Persistent Systems Ltd. | 2.96% |
Fortis Healthcare Ltd. | 2.95% |
GE Vernova T&D India Ltd | 2.81% |
PB Fintech Ltd. | 2.64% |
Kaynes Technology India Ltd. | 2.52% |
Cummins India Ltd. | 2.52% |
The Federal Bank Ltd. | 2.44% |
Dixon Technologies (India) Ltd. | 2.39% |
UNO Minda Ltd. | 2.18% |
Name | Assets |
|---|---|
AU Small Finance Bank Ltd. | 5.59% |
Swiggy Ltd. | 5.23% |
The Federal Bank Ltd. | 5.07% |
L&T Finance Ltd. | 4.89% |
Prestige Estates Projects Ltd. | 4.59% |
BSE Ltd. | 4.04% |
Max Financial Services Ltd. | 4.02% |
Glenmark Pharmaceuticals Ltd. | 3.78% |
Sai Life Sciences Ltd. | 3.30% |
JK Cement Ltd. | 3.19% |
Name | Nishita Shah | Amit Ganatra |
Start Date | 24 May 2023 | 03 Oct 2025 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equities and equity linked securities of mid cap segment. | The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies |
Launch Date | 28 Jul 2022 | 15 Feb 2007 |
Description
Launch Date